Patent ID: 8507522
Filing Date: 2013-08-13
Classification: A61K,A61P,C07D

Abstract:
1. A compound of Formula (II), or a pharmaceutically acceptable salt thereof: E is absent or a cyclic group independently selected from aryl, heteroaryl, heterocyclic, C T is absent or an optionally substituted aliphatic group: Ring G is a 5/6-membered fused heteroaryl other than benzimidazolyl, wherein the 6-membered ring of said 5/6-membered fused heteroaryl is attached to T, and wherein the 5-membered ring of said 5/6-membered fused heteroaryl is attached to group Q and contains one or more nitrogen atoms; and wherein said 5/6-membered fused heteroaryl is optionally substituted: Wherein Q in Formula II is represented by R R R R R m is 0, 1, or 2; n is 1, 2, 3, or 4; X at each occurrence is independently selected from O, S, S(O), SO R